![Bo Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Bo Liang has held the title of Vice President-Chemical at Shanghai Zhimeng Biopharma, Inc. since 2015.
He is also the founder of Shanghai Zhimeng Biopharma, Inc. which was founded in 2015.
Cargos activos de Bo Liang
Empresas | Cargo | Inicio |
---|---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Fundador | 26/10/2015 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Health Technology |
- Bolsa de valores
- Insiders
- Bo Liang